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Abstract 
Many mathematical and computational models have been developed to investigate the complexity of HIV dynamics, immune 
response and drug therapy. However, there are not many models which consider the dynamics of virus intracellular replication at 
a single level. We propose a model of HIV intracellular replication where infected cells undergo a single cycle of virus 
replication. A cell is modeled as an individual entity with certain states and properties. The model is stochastic and keeps track of 
the main viral proteins and genetic materials inside the cell. Two simulation approaches are used for implementing the model: 
rate-based and diffusion-based approaches. The results of the simulation are discussed based on the number of integrated viral 
cDNA and the number of viral mRNA transcribed after a single round of replication. The model is validated by comparing 
simulation results with available experimental data. Simulation results give insights about the details of HIV replication dynamics 
inside the cell at the protein level. Therefore the model can be used for future studies of HIV intracellular replication in vivo and 
drug treatment. 
Keywords: HIV-1 intracellular replication, Agent-Based Simulation 
1. Introduction 
In the field of virology and infectious diseases, mathematical and computational models are developed to provide 
a better understanding of the underlying biological phenomena and medical processes. In recent years, many 
computational models have been developed to investigate the complexity of HIV dynamics, immune system 
response, and drug therapy [1-5]. Simulation of HIV infection can vary from modeling the entire immune response 
(under virus infection and drug therapy) [30] to simulating the intracellular processes at a molecular level. A 
concrete example of this wide-range multi-scale modeling is HIV Decision Support: From Molecule to Man by 
Sloot et al. (2009) [6, 7]. Despite the wide range of modeling for HIV dynamics, more and more attention is being 
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paid toward single cell analysis to understand intracellular processes. 
At cellular and molecular level different modeling techniques, from deterministic to stochastic [12] and from 
mathematical to agent-based models [8, 9, 11], have been used to simulate the intracellular process of viral 
replication. A mathematical model by Reddy et al. (1999) [8] was used to study intracellular kinetics of HIV-1 
replication. Reddy’s model is based on a system of coupled ordinary differential equations (ODEs) that is solved 
numerically. Each sub-process of the viral replication cycle is represented by one or more equations. The model 
provides concentration-based insights on how the overall replication cycle depends on its constituent reactions. 
Although mathematical models are able to represent the overall behavior of the system, a disadvantage is that they 
are less helpful in capturing the individual interactions of the system components, ignoring spatial and topological 
dependencies. On the other hand Agent-Based Simulation (ABS), an emerging field in modeling microbiological 
phenomena, has been widely used in modeling at cellular and molecular levels [3, 9, 13, 14, 15]. In ABS cells and 
molecules are modeled as individual agents and the complex behavior of the system emerges from their interactions. 
A model using ABS principles was CellAK by Webb et al. (2004) [9]. It includes cellular details such as membrane 
with lipid bilayers, substrate molecules and enzymes with reaction rules and metabolic pathways. The cellular 
entities are modeled as agents and the cell behavior emerges from the interaction between agents. Although agent-
based modeling has advantages in modeling biological and microbiological systems, such models are 
computationally more expensive than ODE mathematical models. This problem is becoming less important 
nowadays with fast super-computers and distributed computing. In modeling HIV infection, agent-based models are 
generally large-scale and no intracellular agent-based model exists that specifically concerns HIV.  
In this paper, we have modeled the HIV-1 intracellular replication and the virus kinetics inside the cell. The rest 
of this article is organized as follows: In Section 2 we describe the HIV replication process and present the general 
model design. Section 3 introduces the two simulation approaches used for implementation. Section 4 presents the 
simulation results which are comparable with the experimental data. Section 5 is the conclusions and future work. 
2. Modeling HIV-1 intracellular replication 
    Despite having a simple structure, HIV has a complex dynamics inside the cell. HIV replication first requires the 
virus to enter an uninfected host cell such as CD4+ cells or macrophages. After the virus enters the cell, it utilizes 
the cell machinery for replication and release of new virions from the cell surface. Figure 1 (a), taken from Gene 
Therapy Journal in ref. [31], illustrates the intra-cellular replication process of HIV-1 from entering the cell to 
releasing new virus particles from the cell. For simplicity, we have only simulated the major steps that are critical in 
the viral replication process. Figure 1 (b) shows the general model design and the main replication steps in the model 
marked in red. The following 7 steps are considered in the model: Reverse transcription, nuclear transport, 
integration, cell activation, mRNA transcription, transport to the cytoplasm and translation.  
    
(a)                               (b)   
Fig. 1. (a) HIV intracellular replication cycle: Entry(Binding to CD4 receptor(1), Co-receptor binding(2), Fusion(3)), Reverse transcription(4,5), 
Transfer to the nucleus(6), Integration (7), Transcription and regulation(8,9,10), Export to the cytoplasm (11), Translation (12), Assembly, 
budding and maturation(13,14,15) [31]; (b) 7 main steps of viral replication in the model. 
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Virus entry to the host cell is not simulated in our model and initiation of infection is modeled as a stochastic 
process explained in Section 2.1. The cell is modelled as an individual entity with certain states and properties. Over 
the course of simulation time, we assume the cell to be non-dividing and non-interacting. In what follows we 
describe the cell infection and different cell states.
2.1.1. Cell infection 
     Cell entry is an important part of the HIV host infection and is target of many drug treatments. In our simulation 
we decided not to model the entry in detail because a simple description was not enough to represent such a complex 
mechanism and we preferred to investigate this aspect in a later study [33]. Moreover, the experimental data used to 
validate the model is based on quantitative methods that use multiplicity of infection (MOI) as a measure of 
infection. MOI is the ratio of virus particles to cells or the average number of virus particles per cell. In real 
experiments the MOI is determined by dividing the number of viruses per ml by the number of cells per ml. 
Therefore, we used the MOI as a measure of infection, rather than measuring the percentage of infected cells by 
explicitly modelling the cell entry, until we have the chance to access data with details on the entry process. Cell 
infection is thus simulated as a stochastic process. For each run the cell may get infected (with 1 or more viruses) or 
remain uninfected based on the MOI. Although the MOI represents the average number of viruses per cell, the 
specific number of viruses that infect any given cell follows a Poisson distribution [16]. In a population, the 
proportion of cells infected by a specific number of viruses is P(n), 
ܲሺ݊ሻ ൌ ௠೙.௘ష೘௡!                                                                                                                                    (1)
where m is the MOI and n is the specific number of viruses infected the cell. For example if m = 1, a higher 
proportion of cells will get infected with one virus or will not get infected at all (n = 0), while some cells may get 
infected with two or more viruses. We have used this approach to substitute the entry process and initiating the cell 
infection. The value of MOI is an input to the model and is specified at the start of the simulation. 
2.2. Cell states and transitions 
     The life cycle of HIV inside the cell is arbitrarily divided into two distinct phases: The early phase refers to the 
steps of replication from cell entry to integration of viral cDNA into the cell DNA, whereas the late phase refers to 
the post-integration steps from cell activation and mRNA transcription to budding and release of new viruses from 
the cell [18]. In this model we have defined 6 states for the cell and each cell has associated a specific state at a time. 
At each time point the cell can be in one of the following states: Uninfected ( ௎ܶூ), early infected ( ாܶூ), latently 
infected ( ௅ܶூ), and actively infected ( ஺ܶூ), productively infected ( ௉ܶூ), and dead ( ஽ܶ).  ௎ܶூ  refers to a healthy cell, 
ாܶூis an infected cell before the viral genome is integrated into its DNA, ௅ܶூ  is the state of a cell which has an 
integrated provirus in its genome. ஺ܶூ is the state of an activated cell which produces new viral mRNAs transcripts, 
and ௉ܶூis the state of an activated cell that starts to produce new viral particles from its surface. Hence, the state of 
the cell may change during its lifespan. Figure 2 shows the state transitions of a cell during the viral replication 
process. 
Fig. 2.  Cell internal states and transitions 
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of the simulation and is used as a probability for stochastic occurrence of events. As soon as the cell is infected ( ாܶூ) 
the reverse transcription process occurs with the average rate of ݇௥௧ nucleotides per minute where the length of HIV 
RNA component is 9479 nucleotides [19]. The reverse transcription process mainly consists of 3 steps: First 
synthesis of the first-strand DNA from the viral RNA, next synthesis of the second-strand DNA and finally the full-
length double-strand DNA formation which leads to viral RNA degradation. We have considered these 3 steps of 
reverse transcription by creation of the first and the second-strand DNAs in our model which together form up a 
full-length viral DNA. Nuclear transfer rate,݇௧௥௔௡௦௙௘௥ , is the rate by which the viral DNA produced by reverse 
transcription transfers to the nucleus. The viral DNA in the nucleus is integrated into the host genome, degraded or 
circulated. DNA circularization is neglected in our model because it is very limited [28]. The viral DNA in the 
nucleus is integrated into the host cell DNA with rate ݇௜௡௧௘௚௥௔௧௜௢௡ and the cell becomes latently infected ( ௅ܶூ). A 
latently infected cell may become activated with an activation rate of ݇௔௖௧௜௩௔௧௜௢௡ ൌ 3 ൈ 10ିଷ per day. Activation of 
the cell is important for a latently infected cell to produce infected mRNA molecules by transcription and marks the 
passage from early stages of infection to the late stages. In the previous model of HIV intracellular replication by 
Reddy et al. [8] all cells were considered to be in an activated state at the time of infection, whereas in our model we 
make a distinction between activated ( ஺ܶூ) and inactivated ( ௅ܶூ) cells. At every time step we check for the cell 
activation. As soon as the cell is activated the transcription process is initiated, otherwise no transcription of viral 
genes occurs in the infected cell. mRNA transcription is obtained by cellular factors and cell activation and there are 
three major classes of transcripts: unspliced, singly spliced, and multi-spliced [20]. In our simulation, we are not 
modeling the splicing event of mRNA transcripts and only consider the full-length mRNAs. Splicing plays 
regulatory roles and is required for efficient mRNA transcription. It basically adds a delay to the process of 
transcription which is balanced in our simulation by the time delay added for stochastic cell activation. The cell 
produces mRNA transcripts at every time step with an average transcription rate of ݇௧௥௔௡௦௖௥௜௣௧௜௢௡ . The viral mRNA 
transcripts are exported to the cell cytoplasm by the export rate ݇௘௫௣௢௥௧. In the cytoplasm the mRNA transcripts are 
translated to viral proteins with translation rate ݇௧௥௔௡௦௟௔௧௜௢௡. The list of rates and parameters used in this approach is 
summarized in Table 1. 
Table 1. Parameters 
Parameters Value Reference 
Reverse transcription rate 165 nucleotides per minute [21] 
Activation rate 3 ൈ 10ିଷper day [22] 
Integration rate  4.5 copies per hour [8] 
Transcription rate 1000 copies per hour [8] 
Translation rate 262 proteins per hour [8] 
Export rate to the cytoplasm 2.6 copies per hour [8] 
Transfer rate to the nucleus 0.012 copies per hour [10] 
Half life of mRNA 0.2 per hour [8] 
Elimination rate of proteins 1.4 ൈ 10ିହ proteins per second [23] 
Death rate of uninfected T cell  (ߤ௎஽) 0.03 per day [18] 
Death rate of infected T cell  (ߤூ஽) 0.5 per day [18] 
     The modeling flowchart of the virus intracellular replication cycle (in the rate-based approach) is presented in 
Figure 4. At the start of the simulation cell gets infected randomly based on MOI. The function Replication is 
executed at each iteration in the simulation. Details of the replication function are shown in the flowchart with a 
remark that the function checks the occurrence of an event at each step by taking a random number between 0 and 1. 
The event occurs if the random number is within the range of the event rate, otherwise it goes to the next step. 
     The advantage of this approach in comparison to ODE models is first the stochasticity of the model which 
appears at every step of virus replication. Also cells in the model are considered as individual entities and by looking 
into these individual cells one can obtain a better understanding of the dynamics of virus replication process at a 
single cell level. 
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bigger than the largest diffusion coefficient known for HIV particles inside the human 293T cells (50-220݊݉ଶ/ݏ݁ܿ) 
[29]. The advantage of this approach is that we take into account the spatial effects of the cell which cannot be 
represented in the rate-based model. We chose the cell radius equal to 40 grid points (gp). The average T cell radius 
is between 4 to 4.5ߤ݉ [25]. Considering the cell size 4ߤ݉ each grid point would be 0.1ߤm. In T lymphocytes the 
diameter of the cell is approximately twice that of its nucleus. Hence, we used the value of 2 for the cell to nucleus 
size ratio [25, 26], so the nucleus radius would be 20 gp. If the length of T cell DNA is 0.6ߤ݉, with having each 
grid point 0.1 ߤm, the DNA length would be 6 gp. The amount of tRNA in the cell is a high value (198000 per cell 
[25]) however, not all the tRNAs are available to the virus, as a primer for reverse transcription, and a large 
proportion is used by the cell machinery. Hence, the initial value of the tRNA is used as a free parameter in the 
model. At the start of simulation, the cell randomly gets infected based on cell infection model (Section 2.1). Then 
the cell and agents are assigned to the simulation grid. At each time step every moving agent performs a random 
movement over the grid area and checks for collision. Events in the model occur upon collision between agents and 
collisions will be processed by the agent-collision rules listed in Table 2. 
Table 2. Agent Collision Rules 
IF COLLISION (agent1-agent2) THEN(event) Rules 
vRNA-tRNA Reverse transcription Produce vDNA, and vRNA degradation 
vDNA-cell nucleus membrane Nucleus transfer vDNA transfers from the cytoplasm to the 
nucleus (cDNA) 
cDNA – cell DNA Integration Produce integrated provirus and reduce 
cDNA 
mRNA – cell nucleus membrane Export to cytoplasm mRNA export from the nucleus to the 
cytoplasm 
      Cell activation, transcription and translation occurs with the same rates and conditions explained in the rate-
based approach. We have considered these rates constant over time. Figure 5 a shows a snapshot of the model 
visualization at the early stages of the simulation. The visualized entities are: the cell, the nucleus and the cellular 
DNA which are all positioned on the center of the grid, while viral RNAs (red) and cellular tRNAs (purple) are 
randomly positioned in the cell cytoplasmic area. Figure 5 b shows a snapshot of the model at the late stages of the 
simulation where viral mRNA (small green) is transcribed from the cell DNA inside the nucleus and viral proteins 
(big green) are translated in the cell cytoplasm. 
                     
(a)                     (b)    
     
Fig. 5. (a) Simulation visualization of early stages of the simulationviral RNAs (red) are assigned to the cell cytoplasm environment. The purple 
circles are the cellular tRNA available in the cell (b) Simulation visualization of late stages of simulation: viral mRNA (small green) mainly in 
the cell nucleus, and translated viral proteins (big green) in the cell cytoplasm. The purple circles are the cellular tRNA available in the cell 
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     The model is implemented in Java programming language for both approaches. We have used MASON (A 
Multi-Agent Simulation library core in Java [27]) libraries and 2D visualization tools in our simulation. The result 
data of each cell at each run are recorded in a Hash Table at certain time points. These times can be changed at start 
of the simulation according to the interest of the experiment. The data saved in the history files are used later for 
analyzing the results in MATLAB.
4. Simulation Results 
Although we modeled the intracellular processes at a single cell level, we are analyzing the results over a 
population of cells. This is closer to what happens in in-vivo and in-vitro experiments, where measurements are an 
average over all the cells in a volume of blood or on a petri dish. In order to compare our model results with the 
experimental data we run the simulation for several populations of cells and average over these populations. At each 
run we compute the first replication cycle up to 72 hours post-infection, corresponding to 3 days, which is 
approximately 12 hours more than the average life-span of an infected cell. In what follows we will discuss the 
simulation results of both approaches described in Section 3.1. 
The initial number of cells in the simulation is set to 10ଷ which is the average number of cells in a ml of blood 
[1]. Integration of viral DNA into the host cell DNA is a key step in the virus replication cycle and if it doesn't 
occur, the virus is incapable of fully replicating and producing new virions. In experiments conducted by Scott et al. 
[28] detection of integrated DNA was accomplished using fluorescence-monitored PCR. They used the MOI = 0.4 
in their experiments and limited their measurements to a single cycle of HIV replication. We used the same MOI 
value in our simulation which indicates that there is on average 0.4 viruses per cell. The simulation results of 
integrated cDNA are shown in Figure 6. The graph in 6 a is a result of the rate-based approach, while 6 b refers to 
the diffusion-based approach. The blue (solid lines) line is the average amount of integrated cDNA per cell over 
time and the red (dashed lines) lines are the standard deviation of the output. Error bars show the experimental data 
that are measured in 12, 24, 48, and 72 hours post-infection [28]. The concentration of the integrated cDNA first 
rises, reaches a plateau and then slowly decreases. The decrease in the number of integrated cDNA reflects the death 
of infected cells. The integrated cDNA is also detected earlier in the simulation results comparing to the 
experimental data. This difference is explained by the limited sensitivity in detection and accurate quantification of 
integrated cDNA in PCR experiments [32]. The simulation results of integrated cDNA are consistent with the 
experimental data in [28]. However, there is an over estimation in the first 36 hours of the diffusion-based approach, 
which is due to the assumptions made on the diffusion of particles inside the cell. The particles inside an infected 
cell are in different sizes and have different diffusion coefficients, but we have assumed the same diffusion 
coefficient for all moving particles. Although this assumption influences the final biological results of the diffusion-
based approach, we are fixing it by improving the missing data values. Nonetheless, the modeling approach would 
still be the same. 
  (a)       (b) 
Fig. 6. Simulation results of integrated cDNA per cell at MOI = 0.4  (average over 10 simulation runs of 1000 cells) (a) Rate-based approach (b) 
Diffusion-based approach 
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     Viral mRNA is the product of transcription process. Once the cell is activated, the transcription process starts. 
We have measured the average copies of mRNA transcripts per cell produced over 1000 cells at different MOIs and 
compared it with experimental data on genomic HIV-1 mRNA molecules. In experiments conducted by Barbosa et 
al. [10], mRNA of two groups of patients with different viral loads was measured. The patients in the first group had 
a high viral load and patients in the second group had a low viral load. Accordingly, we choose a range for MOI 
from 0.01 to 10 and run the simulation for certain values in this range. Then we plot the average amount of mRNA 
transcripts produced after 72 hours in each run versus the value of MOI in that run (Figure 7 a). The y-axis is the 
amount of mRNA transcripts produced per cell (72 hours post-infection) and x-axis is the MOI range. Figure 4 a is 
the results of the rate-based approach and each data point is an average over 1000 cells. The red bars show the range 
of mRNA produced per cell in the two groups of patients with high (solid bar) and low (dashed bar) viral loads.  
From these data points we observed that the simulation results of viral mRNA produced per cell is within the same 
range (1. 0 ൈ 10ିଶ-1.0 ൈ 10ଶgenomes per cell) as the data collected from patients in experiment [10]. Figure 7 b 
illustrates the trend of viral mRNA production over time for certain MOI values in the rate-based approach. We can 
see that as the value of MOI increases, the cell activation and transcription processes start earlier and more mRNA 
transcripts are produced. 
        (a)          (b) 
Fig. 7. (a) Number of HIV mRNA molecules per cell (y-axis) at deferent MOIs (x-axis). Each data point is an average over 1000 cells. (b) Trend 
of mRNA production over time for different MOI values. Simulation results mRNA per cell 
5. Conclusions 
We presented a model of HIV-1 intracellular replication, where infected cells undergo a single cycle of virus 
replication. The cell is an individual entity and cell infection is modelled by a stochastic process. The model keeps 
track of the main viral proteins and genetic materials inside the cell during the virus replication. Using this model we 
analyzed each step of the viral replication cycle from reverse transcription to translation. Two simulation approaches 
were used for implementing the model: rate-based approach and diffusion-based approach. In the rate-based 
approach the intracellular dynamics of the cell is based on the rates that are inferred from literature, while in the 
diffusion-based approach the dynamics is based on the modelling intracellular compartments as diffusing agents. 
Therefore, in the diffusion-based approach the spatial information of the cell is taken into account. The simulation 
results on the amount of cDNA integrated into the host DNA and the number of mRNA transcripts produced per cell 
were consistent with the experimental data.  
Both simulation approaches are stochastic and by looking at individual cells we get a more realistic description of 
the dynamics inside the cell. This is a more precise description of the in-vivo and in-vitro experiments compared to 
the large-scale deterministic models in the literature. For future directions the model can be adapted or extended in 
both single-cell level and population level. The diffusion-based approach can be extended at the single cell level to 
focus more on the behaviour of the cell under viral replication. A more detailed description of the replication 
processes such as the movement of particles along the microtubules or the regulatory effects of mRNA splicing will 
N. Zarrabi et al. / Procedia Computer Science 1 (2012) 555–564 563
Author name / Procedia Computer Science 00 (2010) 000–000 
allow a better understanding of the intracellular mechanisms. At a population level the rate-based approach can be 
extended to simulate re-infection and interaction between cells such as cell-cell transmission of the virus. So far, our 
model focuses on the first round of replication, while it can be enhanced to have a second, third or multiple rounds 
of replication.  Both approaches in modeling HIV intracellular replication as a whole can be used for investigating 
the effect of various HIV inhibitors or new drug agents on the replication process. Effect of various drugs can be 
modeled either in the form of rates or real agents. This will help to identify the efficiency of drugs acting at different 
stages of virus replication. 
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